Clinical Trials Logo

Cognitive Dysfunction clinical trials

View clinical trials related to Cognitive Dysfunction.

Filter by:

NCT ID: NCT04666077 Recruiting - Clinical trials for Mild Cognitive Impairment

Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

Start date: August 27, 2019
Phase: N/A
Study type: Interventional

This study compares different music therapy (MT) experiences and their impact on memory and language in patients with Alzheimer's disease and Mild Cognitive Impairment. The 12-month study will assess the role of common experiences involving familiar music and other pleasant events (blinded control) to benefit cognition and measure the quality of life for people with Alzheimer's disease and Mild Cognitive Impairment. Following screening, all participants will meet with a licensed music therapist at the first study visit. Thereafter, each group will have an individualized schedule of follow-up telephone calls and visits. Screening for the study and participation in the study intervention can be completed in-person or from your home, if you do not live in the area.

NCT ID: NCT04658654 Recruiting - Clinical trials for Mild Cognitive Impairment

Cognitive Effects of Roflumilast in (a)MCI and Mild Dementia Patients

ROMEMA
Start date: November 19, 2021
Phase: Phase 2
Study type: Interventional

The aim of the current project is to validate whether chronic intake (24 weeks) roflumilast (PDE4 inhibitor) can improve cognition in patients with (amnestic) mild cognitive impairment (MCI) and in patients with mild dementia. The project will demonstrate whether episodic memory, but also attention, information processing or executive function improves with chronic administration of roflumilast in (a)MCI and mild dementia patients.

NCT ID: NCT04658290 Recruiting - Clinical trials for Obstructive Sleep Apnea

Prevalence of Obstructive Sleep Apnea (OSA) and the Association With Cognitive Impairment

Start date: August 29, 2020
Phase:
Study type: Observational

The study is aimed to carry out an epidemiology study investigating the prevalence of obstructive sleep apnea (OSA) and the association with cognitive impairment.

NCT ID: NCT04656860 Recruiting - Clinical trials for Mild Cognitive Impairment

Juice Plus Supplement Clinical Trial

Start date: March 12, 2020
Phase: N/A
Study type: Interventional

The study is designed to determine whether encapsulated fruit and vegetable juice concentrates can improve biological indicators of cognitive and multiple dimensions of memory and learning.

NCT ID: NCT04643327 Recruiting - Parkinson Disease Clinical Trials

Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease

TRIP
Start date: February 9, 2021
Phase: Phase 2
Study type: Interventional

The present study is a proof-of-concept clinical trial to test the efficacy of low doses of a repurposed anti-epileptic drug (levetiracetam) in treating memory problems in Parkinson's disease (PD). Neuroimaging techniques will be used to determine the effect of the drug on specific brain regions (hippocampal subfields). Finally, baseline brain activity of PD patients with memory problems will be compared to PD patients without memory problems and healthy older adults to determine if activity in specific brain regions (hippocampal subfields) can be used to predict memory problems in PD. This information will be useful for future clinical trials to target drugs to these brain regions.

NCT ID: NCT04643132 Recruiting - Postoperative Pain Clinical Trials

S-ketamine Prevents Postoperative Pain and Cognitive Dysfunction After Tibial Fracture

Start date: December 15, 2020
Phase: N/A
Study type: Interventional

Purpose: To explore effects of S-ketamine on postoperative pain and cognitive dysfunction after tibial fracture and orthopedic surgery. To evaluate and examine the incidence of adverse effects with the purpose of selecting the optimum dose.

NCT ID: NCT04638478 Recruiting - Meningioma Clinical Trials

PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI

Start date: April 8, 2021
Phase:
Study type: Observational

Meningioma are slow growing and frequently occurring intracranial tumors, responsible for 33% of all asymptomatic intracranial tumors and 13-26% of all symptomatic primary brain tumors. The 10-year survival rate is 72%. A variety of treatment options is available for symptomatic meningioma including surgical removal with or without radiotherapy or radiotherapy alone. These therapies can have negative impact on cerebral functioning. After high dose radiotherapy for primary or metastatic brain tumors 50-90% of > 6 months' survivors develop irreversible disabling cognitive decline leading to premature loss of independence, reduced Quality of Life (QOL) as well as significant economic burden both at the individual as societal level. Especially for patients with a good prognosis like benign meningioma, maintaining neurocognitive function is crucial. Understanding the mechanisms underlying radiation induced cognitive decline is complex and which brain areas to spare are an important subject of research. Evaluation methods to assess cognitive function and predict cognitive decline are urgently needed, this will allow the development of optimized treatment strategies with the aim to preserve or even improve cognitive function in meningioma patients. Improvements in the field of neuroimaging techniques (i.e. advanced MRI techniques) have the possibility to identify areas susceptible to cognitive impairment. This allows in the future a more personalized radiation treatment by identifying patients at risk, by optimizing the radiotherapy dose to specific brain regions, that could eventually reduce or prevent, cognitive decline. Improvements in the field of radiotherapy for example by higher precision treatment such proton therapy have potential in obtaining these more individualized strategies.

NCT ID: NCT04635657 Recruiting - Clinical trials for Cognitive Impairment

Cognitive Status After Removal of Skull Base Meningioma

Start date: December 10, 2019
Phase:
Study type: Observational

The purpose of this prospectively enrolling trial is to assess long-term cognitive outcomes of patients undergoing surgery for resection of a meningioma associated with the frontal and temporal lobes.

NCT ID: NCT04634656 Recruiting - Clinical trials for Cognitive Dysfunction, Postoperative

Lidocaine on Early Cognitive Dysfunction in Shoulder Arthroscopy

Start date: January 7, 2021
Phase: Phase 2
Study type: Interventional

The beach chair position (BCP) combined with deliberate hypotension impair cerebral perfusion pressure and oxygenation during arthroscopic shoulder surgeries and produce cerebral ischemia.

NCT ID: NCT04629495 Recruiting - Alzheimer Disease Clinical Trials

Rapamycin - Effects on Alzheimer's and Cognitive Health

REACH
Start date: August 11, 2021
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety, tolerability, and feasibility of 12 month oral rapamycin treatment in older adults with amnestic mild cognitive impairment (aMCI) and early stage Alzheimer's disease (AD).